Week of April 30 - 06, 2017


Niraparib (Zejula™)

Niraparib is a PARP inhibitor used in the treatment of ovarian, fallopian tube, endometrial and primary peritoneal cancers.

Avelumab (Bavenicio ®)

Avelumab (Bavenicio ®) is a programmed death ligand-1 (PD-L1) blocking antibody used in the treatment of Merkel cell carcinoma. 

Telotristat (Xermelo™)

Telotristat (Xermelo™) is a tryptophan hydroxylase inhibitor used to treat diarrhea related to carcinoid syndrome.

Ribociclib (Kisqali®)

Ribociclib (Kisquali®) is used in the treatment of hormone receptor positive, HER2 negative, advanced or metastatic breast cancer in post-menopausal women. 

First Bite Syndrome

First bite syndrome is a side effect of some head and neck cancer tumors or treatments that causes mouth pain when salivating or taking the first couple bites of food. 

Cervical Dystonia

Cervical dystonia is a side effect which causes neck muscles to contract on their own causing abnormal movements and abnormal posture of the head and neck.

Radiation Fibrosis Syndrome

Radiation fibrosis syndrome is a common late side effect of radiation in the treatment of head and neck cancer.

Trismus

Information about the side effect trismus and how it is treated. 

Spinal Accessory Nerve Palsy

Information about Spinal Accessory Nerve Palsy, a side effect of some treatments for head and neck cancers. 

Proton Therapy for Head & Neck Cancers: Webinar

This webinar provides an introduction to the treatment of head and neck cancers, with a focus on radiation therapy and specifically the treatment of head and neck cancers with proton therapy.

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
R
S
T
U
V
X
Y
Z
#
 
A
B
C
E
F
G
H
K
L
M
N
O
P
R
S
T
U
V
 
 
Manténgase informado con las últimas informaciones de OncoLink!   Suscribirse a OncoLink eNews
Ver nuestros archivos de boletines